BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25825265)

  • 1. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
    Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
    Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure.
    Rinaldi B; Capuano A; Gritti G; Donniacuo M; Scotto Di Vettimo A; Sodano L; Rafaniello C; Rossi F; Matera MG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):109-13. PubMed ID: 24769100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.
    Navaratnarajah M; Siedlecka U; Ibrahim M; van Doorn C; Soppa G; Gandhi A; Shah A; Kukadia P; Yacoub MH; Terracciano CM
    PLoS One; 2014; 9(9):e92909. PubMed ID: 25268495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic β-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat.
    Chan V; Fenning A; Hoey A; Brown L
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):424-31. PubMed ID: 21709583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.
    Ahmet I; Morrell C; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2009 Oct; 331(1):178-85. PubMed ID: 19587314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
    Ahmet I; Lakatta EG; Talan MI
    Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
    Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
    Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E; Bollano E; Soussi B; Waagstein F
    Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
    Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
    J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cardiac events caused by surgical stress in aged rats: simultaneously activating β2-adrenoceptor and inhibiting β1-adrenoceptor.
    Sun Y; Wang Y; Zhang L; Xu C; Liu Y; Kang S; Yan C; Li D; Sun H
    Stress; 2014 Jul; 17(4):373-81. PubMed ID: 24754893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction.
    Babick A; Elimban V; Zieroth S; Dhalla NS
    J Cell Physiol; 2013 Oct; 228(10):2063-70. PubMed ID: 23553674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological and clinical profile of indacaterol maleate (Onbrez®), an inhaled long-acting β₂-adrenoceptor agonist].
    Suzuki K; Uchiyama M; Matsushima S; Yoshiki M; Kitawaki T
    Nihon Yakurigaku Zasshi; 2012 Jul; 140(1):36-43. PubMed ID: 22790232
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M; Mackiewicz U
    Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (a Combination of) the Beta
    Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
    Cells; 2021 May; 10(5):. PubMed ID: 34069899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of β
    Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?
    Thireau J; Karam S; Roberge S; Roussel J; Aimond F; Cassan C; Gac A; Babuty D; Le Guennec JY; Lacampagne A; Fauconnier J; Richard S
    Heart; 2014 Jun; 100(11):833-41. PubMed ID: 24667281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.